Daniel Tassé, President and Chief Executive Officer, joined Ikaria in his current role in January 2008. He previously served as General Manager of Baxter International's Pharmaceuticals & Technologies business, a division created by integrating the company's Anesthesia, Critical Care and BioPharma Solutions Business units. Prior to his tenure at Baxter International, Mr. Tassé held senior management positions at GlaxoSmithKline and Upjohn. He has a B.Sc. in Biochemistry from the University of Montreal.